Dr. Marion Laderoute brings exceptional expertise to the field of infectious disease research, with a distinguished career spanning decades in both public service and independent research. Beginning as a medical lab technologist, she advanced through academic achievements including a BSc in Microbiology from the University of Alberta, a PhD in medical sciences and immunology, and a postdoctoral fellowship at the Cross Cancer Institute in Edmonton. Her federal service from 1996 to 2011 focused on protecting Canadians from infectious disease risks in biological products. As an inventor and discoverer of HERV-K102 as a protective virus in the human genome, which she refers to as the ‘angel virus of humans,’ Dr. Laderoute has established herself as a global expert in trained innate immunity of foamy macrophages and their role in protecting against pandemics and cancers. Since retiring from government service, she has continued groundbreaking independent research, publishing extensively on immune complex pathology and vaccine shedding through platforms like Substack and X, making complex scientific concepts accessible to the public while maintaining rigorous scientific standards.
* The above video is being streamed via Rumble. Check back often as we continue to update the complete list of links to all witness testimonies in both video and audio/podcast formats.
The transcript for this witness testimony is currently in production by our volunteers. It will be available soon here on this page and as a downloadable PDF.
Summary
Dr. Laderoute presents revolutionary findings showing that mRNA COVID-19 vaccines from Pfizer and Moderna induce dangerous spike-specific IgG1 and IgG3 antibodies in the upper respiratory tract, fundamentally changing how SARS-CoV-2 affects the human body. She explains that these antibodies create what she terms ‘bioweaponized SARS-CoV-2’ that can be transmitted from vaccinated to unvaccinated individuals through a process called shedding, expanding risk from elderly and sick populations to include healthy children and adults. Her analysis of UK Office for National Statistics data reveals over 500,000 non-COVID deaths she attributes to shedding in the first 17 months of vaccine rollout, with similar patterns found in US data showing over 800,000 such deaths. She demonstrates that unlike natural infection or other vaccine types, only mRNA vaccines create these dangerous antibodies in the upper respiratory tract, which bind complement and can initiate clotting processes when transmitted to others. The research shows children under 18 experienced a 3-4 fold increase in serious adverse events correlating with major shedding events, with evidence of genetic integration risks from Pfizer vaccines specifically. Dr. Laderoute recommends immediate withdrawal of mRNA vaccines from the market, testing of vaccine vials for spike protein contamination, and investigation of natural alternatives like vitamin D3 supplementation and beta-glucans from oatmeal to boost protective HERV-K102 particles and trained innate immunity as safer pandemic preparedness strategies.
Credentials
Dr. Marion Laderoute is a retired federal infectious disease specialist who worked with the Government of Canada from 1996 to 2011, specializing in infectious disease risk minimization through biological products. She continues independent research on immune complex pathology and vaccine shedding, publishing analyses on various social media platforms. Dr. Laderoute presents groundbreaking research on how mRNA COVID-19 vaccines create dangerous spike-specific antibodies in the upper respiratory tract, leading to what she terms ‘bioweaponized SARS-CoV-2’ that can be transmitted to unvaccinated individuals. She reveals evidence of over 500,000 ‘shedding deaths’ in the UK and recommends immediate withdrawal of mRNA vaccines while suggesting natural alternatives like vitamin D3 and oatmeal to boost protective immunity.\n\nDr. Laderoute brings exceptional expertise to the field of infectious disease research, with a distinguished career spanning decades in both public service and independent research. Beginning as a medical lab technologist, she advanced through academic achievements including a BSc in Microbiology from the University of Alberta, a PhD in medical sciences and immunology, and a postdoctoral fellowship at the Cross Cancer Institute in Edmonton. As an inventor and discoverer of HERV-K102 as a protective virus in the human genome, which she refers to as the ‘angel virus of humans,’ Dr. Laderoute has established herself as a global expert in trained innate immunity of foamy macrophages and their role in protecting against pandemics and cancers. Since retiring from government service, she has continued groundbreaking independent research, publishing extensively on immune complex pathology and vaccine shedding through platforms like Substack and X, making complex scientific concepts accessible to the public while maintaining rigorous scientific standards.








